{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:32:02Z","timestamp":1790184722242,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.parkreldis.2008.01.010","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T07:59:41Z","timestamp":1205395181000},"page":"600-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy"],"prefix":"10.1016","volume":"14","author":[{"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladi","family":"Bentho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Moak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehonatan","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Imrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shielah","family":"Conant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil A.","family":"Eldadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2008.01.010_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jcbfm.1993.8","article-title":"6-[18F]Fluoro-l-dopa metabolism in living human brain: a comparison of six analytical methods","volume":"13","author":"Hoshi","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03164771","article-title":"Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG","volume":"11","author":"Otsuka","year":"1997","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.wnl.0000268696.57912.64","article-title":"Cardiac sympathetic denervation, baroreflex failure, and nigrostriatal dopamine deficiency in Parkinson disease from LRRK2 gene mutation","volume":"69","author":"Goldstein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib5","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1212\/WNL.42.11.2111","article-title":"Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group","volume":"42","author":"LeWitt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0404.1995.tb01023.x","article-title":"CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease","volume":"92","author":"Eldrup","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","article-title":"What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study","volume":"54","author":"Litvan","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.58.2.160","article-title":"Clinicopathological study of 35 cases of multiple system atrophy","volume":"58","author":"Wenning","year":"1995","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"Pt 12","key":"10.1016\/j.parkreldis.2008.01.010_bib9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/brain\/120.12.2187","article-title":"Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease","volume":"120","author":"Antonini","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jnnp.51.7.914","article-title":"Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure","volume":"51","author":"Polinsky","year":"1988","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00002512-200118070-00003","article-title":"Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management","volume":"18","author":"Senard","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/WNL.58.4.575","article-title":"Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD","volume":"58","author":"Schocke","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/mds.21614","article-title":"Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy","author":"Kollensperger","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.2004.049221","article-title":"Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound","volume":"76","author":"Behnke","year":"2005","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-2952(90)90538-V","article-title":"Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions","volume":"40","author":"Baldessarini","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0891-0618(01)00122-3","article-title":"D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain","volume":"22","author":"Hurd","year":"2001","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.57.6.1140","article-title":"Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA","volume":"57","author":"Orimo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","article-title":"Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy","volume":"73","author":"Orimo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"Amino","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","article-title":"Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy","volume":"113","author":"Orimo","year":"2007","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib22","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.WNL.0000161874.52302.5D","article-title":"[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease","volume":"64","author":"Siderowf","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib23","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/mds.21083","article-title":"Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy","volume":"21","author":"Lee","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00415-003-0248-4","article-title":"Olfactory dysfunction in cerebellar ataxia and multiple system atrophy","volume":"250","author":"Abele","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01829019","article-title":"Olfactory dysfunction in the Shy-Drager syndrome","volume":"3","author":"Nee","year":"1993","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02291236","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy","volume":"6","author":"Kaufmann","year":"1996","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"8","author":"Gilman","year":"1998","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02281111","article-title":"Non-invasive detection of sympathetic neurocirculatory failure","volume":"10","author":"Goldstein","year":"2000","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20020315","article-title":"Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension","volume":"104","author":"Goldstein","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4347(93)E0430-X","article-title":"Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection","volume":"653","author":"Holmes","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10641969709080812","article-title":"Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans","volume":"19","author":"Goldstein","year":"1997","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ana.410280427","article-title":"Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans","volume":"28","author":"Lang","year":"1990","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2008.01.010_bib34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/113.5.1539","article-title":"The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET","volume":"113","author":"Brooks","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.47.3.718","article-title":"Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease","volume":"47","author":"Wilson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib38","first-page":"59","article-title":"Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases","volume":"43","author":"Spokes","year":"1979","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1054\/jocn.2001.1071","article-title":"Olfactory function in Parkinsonian syndromes","volume":"9","author":"Muller","year":"2002","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib40","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/mds.20229","article-title":"Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease","volume":"19","author":"Seppi","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2008.01.010_bib41","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/0735-1097(93)90786-Z","article-title":"Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans","volume":"22","author":"Goldstein","year":"1993","journal-title":"J Am Coll Cardiol"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802008000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:10:48Z","timestamp":1761178248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802008000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1353802008000345"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2008.01.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2008.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}